Bilingualism has long been known to have cognitive benefits for older adults. Research shows it helping delay the onset of Alzheimer’s disease by up to five years compared to monolingual adults.
Roche’s Columvi passes Phase 3 lymphoma test as competition with AbbVie, Genmab continues
Roche’s Columvi is on the path to a full approval and potentially a label expansion in an earlier lymphoma setting after hitting the primary endpoint
April 16, 2024